Effect of ventricular fibrillation duration on the defibrillation threshold in humans

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 1, 2002, Pages 14-19

  Gradaus, Rainer ^a   Bode Schnurbus, Lucas ^a   Weber, Max ^a   Rötker, Jürgen ^b   Hammel, Dieter ^b   Breithardt, Günter ^a   Böcker, Dirk ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Cardiothoracic Surgery   (Germany)

Author keywords

Defibrillation threshold; Implantable cardioverter defibrillator; Ventricular fibrillation

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEFIBRILLATION; DEFIBRILLATION THRESHOLD; DEFIBRILLATOR; DISEASE DURATION; ELECTRIC POTENTIAL; FEMALE; HEART DILATATION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MALE; SYMPATHETIC INNERVATION; SYNCOPE; T WAVE; TREATMENT OUTCOME;

CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 0036159285     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.00014.x     Document Type: Article

References (23)

1. Electrophysiological mechanisms involved in ventricular fibrillation
2. Myocardial activation at the onset and during ventricular fibrillation
3. Mechanism of ventricular vulnerability to single premature stimuli in open-chest dogs
4. The transition to ventricular fibrillation induced by reperfusion after acute ischemia in the dog: A period of organized epicardial activation
5. Influence of ventricular fibrillation duration on defibrillation energy in dogs using bidirectional pulse discharges
6. Effect of duration of ventricular fibrillation on defibrillation efficacy in humans
7. The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in human
8. The effects of ventricular fibrillation duration and site of initiation on the defibrillation threshold during early ventricular fibrillation
9. Effect of ventricular dilatation on defibrillation threshold in the isolated perfused rabbit heart
10. Left and right ventricular dimensions during ventricular fibrillation in the dog
11. Effects of ventricular fibrillation on coronary blood flow and myocardial metabolism
12. Cardiac sympathetic nervous activity during myocardial ischemia, reperfusion and ventricular fibrillation in the dog-effects of intravenous lidocaine
13. The Antiarrhythmics Versus Implantable Defibrillator (AVID) investigators A comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from near-fatal ventricular arrhythmias
14. Potential benefit from ICD-therapy in patients with and without heart failure
15. Canadian implantable defibrillator study (CIDS): A randomized trial of implantable cardioverter defibrillator against amiodarone
16. Defibrillation threshold and perioperative mortality associated with endocardial and epicardial defibrillation lead systems
17. A prospective randomized evaluation of biphasic versus monphasic waveform pulses on defibrillation efficacy in humans
18. A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans
19. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system
20. Comparison of a unipolar defibrillation system with a dual lead system using an enlarged defibrillation anode
21. Syncope in patients with an implantable cardioverter-defibrillator: Incidence, predictors and implications for driving restrictions
22. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability
23. Recurrent appearance of protective zones after an unsuccessful defibrillation shock